TPG Pace Holdings (TPGH) Releases Extension Vote Info
by Kristi Marvin on 2019-09-20 at 4:53pm

Early this afternoon, TPG Pace Holdings Corp. (TPGH), released the details of their shareholder vote to approve their new extension deadline and the results were 100% in favor of extending.  In fact, I don’t ever recall a SPAC vote (off the top of my head) where 100% percent of voters checked off the “yes’ box. However, there were some redemptions, but as a result of today’s vote, TPGH will now have until December 31, 2019, to close their transaction with Accel Entertainment.

RESULTS

Per the 8-K, 3,247,267 of the Company’s Class A Ordinary Shares elected to redeem at a price of $10.29 share, which resulted in $33.4 million being removed from the Trust Account leaving approximately $429.7 million remaining.  As a reminder, TPGH will not be contributing any additional capital to trust for shareholders who did not redeem.

Additionally, TPGH recently filed their preliminary proxy/S-4 (September 5th), so a shareholder vote to complete will hopefully occur well before December 31st, but this extension gives them some cushion.  Look for a new proxy early to mid-October.

You can review the results of the vote HERE, but a summary has also been provided below.

 

The Extension Amendment:

 

FORAGAINSTABSTAINBROKER NON-VOTES
46,892,22200N/A
Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved